Publicaciones en colaboración con investigadores/as de Pontifícia Universidade Católica do Rio Grande do Sul (13)

2024

  1. Effects of a remotely supervised resistance training program on muscle strength and body composition in adults with cystic fibrosis: Randomized controlled trial

    Scandinavian Journal of Medicine and Science in Sports, Vol. 34, Núm. 1

2023

  1. Improvements in Compassion and Fears of Compassion throughout the COVID-19 Pandemic: A Multinational Study

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3

2022

  1. Compassion Protects Mental Health and Social Safeness During the COVID-19 Pandemic Across 21 Countries

    Mindfulness, Vol. 13, Núm. 4, pp. 863-880

  2. GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer

    Future Oncology, Vol. 18, Núm. 34, pp. 3801-3813

  3. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

    New England Journal of Medicine, Vol. 387, Núm. 3, pp. 217-226

2021

  1. Fears of compassion magnify the harmful effects of threat of COVID-19 on mental health and social safeness across 21 countries

    Clinical Psychology and Psychotherapy, Vol. 28, Núm. 6, pp. 1317-1333

  2. The role of social connection on the experience of COVID-19 related posttraumatic growth and stress

    PLoS ONE, Vol. 16, Núm. 12 December

2020

  1. Enhancing global access to cancer medicines

    CA Cancer Journal for Clinicians, Vol. 70, Núm. 2, pp. 105-124

  2. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

    The Lancet, Vol. 396, Núm. 10265, pp. 1817-1828

2017

  1. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

    Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 362-375

  2. Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy

    Breast Cancer Research, Vol. 19, Núm. 1

  3. Research needs in breast cancer

    Annals of Oncology, Vol. 28, Núm. 2, pp. 208-217

2013

  1. Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial

    Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649